Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Industry Associations
BioNSW runs an Industry Associations operation from Sydney, New South Wales. Ownership is a nonprofit; it publishes at bionsw.org. It holds one address on record, all in Australia. The record counts 24 people. One Australian registration (ABN) is a confirmed match. The record links eight similar brands, most of them in Biotechnology Research.
ABN85933235254
| BIONSW INCORPORATED | ABN 85933235254 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
BioNSW is the non-for-profit, industry association for Life Sciences in New South Wales, Australia. We hope to represent and connect innovators, investors, manufacturers and legislators across the state.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One New South Wales entity on the ABR. BIONSW INCORPORATED (ABN 85 933 235 254), high confidence.
The record holds 24 counted staff profiles at January 2026, above the self-reported 2–10 band.
One address on record, Australia only. Primary: Sydney, New South Wales 2000.
None linked to this brand.
16 profiles list BioNSW as a peer — 90th percentile in Industry Associations. It lists ten peers of its own. Global Pharma Solutions and Racura Oncology list it back.